Shanghai Model Organisms Center, Inc. (SHA:688265)

SHA:688265 Revenue

Shanghai Model Organisms Center had revenue of 136.14M CNY in the quarter ending September 30, 2026, with 27.30% growth. This brings the company's total for the last twelve months to 486.90M, up 16.18% year-over-year. In the year 2025, Shanghai Model Organisms Center had annual revenue of 421.02M with 10.44% growth. That makes Shanghai Model Organisms Center the 25,102nd largest company in the world by revenue and 4,485th in China.

• Revenue (ttm): 486.90M
• Revenue Growth: +16.18%
• P/S Ratio: 7.51
• Revenue / Employee: 507.71K
• Employees: 959
• Market Cap: 3.66B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Standardized Model 203.02M 48.5%
• Model Breeding 80.04M 19.1%
• Drug Efficacy Evaluation and Phenotypic Analysis 58.87M 14.1%
• Feeding Service 36.35M 8.7%
• Custom Model 33.32M 8.0%
• Other Model Biotechnology Services 6.69M 1.6%

By Geography

Chart

• China 359.90M 86.0%
• Overseas 58.39M 14.0%

Fiscal year ended Dec 31, 2025 See the full SHA:688265 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	421.02M	39.78M	10.44%
Dec 31, 2024	381.24M	14.69M	4.01%
Dec 31, 2023	366.55M	63.58M	20.99%
Dec 31, 2022	302.97M	27.70M	10.06%
Dec 31, 2021	275.27M	79.08M	40.31%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error